Harm van Tinteren
Active 1971–2025
- 143
- Papers
- 27,358
- Citations
- 89
- h-index
- 140
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine71.3%
- Biochemistry, Genetics and Molecular Biology20.9%
- Immunology and Microbiology3.8%
- Engineering1.3%
- Computer Science0.8%
- Materials Science0.5%
- Other1.4%
Topics
- Cancer Immunotherapy and Biomarkers6.4%
- Intraperitoneal and Appendiceal Malignancies3.7%
- Immunotherapy and Immune Responses3.5%
- CAR-T cell therapy research2.6%
- Cancer Genomics and Diagnostics2.6%
- Ovarian cancer diagnosis and treatment2.6%
- Other78.6%
Coauthors
- Marry M. van den Heuvel‐Eibrink26
- Norbert Graf25
- Kathy Pritchard‐Jones20
- Jan Godziński18
- Christophe Bergeron17
- Beatriz de Camargo16
- Gordan Vujanić16
- Egbert F. Smit14
- Karolina Sikorska13
- Bengt Sandstedt11
- Simon Horenblas11
- Jan de Kraker10
- Gema Ramírez9
- John B.A.G. Haanen9
- Otto S. Hoekstra9
- Renato A. Valdés Olmos9
- Filippo Spreafico8
- Harry J.M. Groen8
- Rhoikos Furtwängler8
- Sabine C. Linn8
- Arnauld Verschuur7
- Christian U. Blank7
- Emiel J. Rutgers7
- Gabe S. Sonke7
All papers
- AACR Project GENIE: Powering Precision Medicine through an International Consortium
Authors: Fabrice André, Mónica Arnedos, Alexander S. Baras, José Baselga, Philippe L. Bédard, Michael F. Berger, Mariska Bierkens, Fabien Calvo, Ethan Cerami, Debyani Chakravarty, Kristen K. Dang, Nancy E. Davidson, Catherine Del Vecchio Fitz, Semih Doğan, Raymond N. DuBois, Matthew D. Ducar, P. Andrew Futreal, Jianjiong Gao, Francisco Moacir Pinheiro Garcia, Stuart M. Gardos, Christopher D. Gocke, Benjamin Groß, Justin Guinney, Zachary Heins, Stephanie Hintzen, Hugo M. Horlings, Jan Hudeček, David M. Hyman, Suzanne Kamel‐Reid, Cyriac Kandoth, Walter Kinyua, Priti Kumari, Ritika Kundra, Marc Ladanyi, Céline Lefèbvre, Michele L. Lenoue-Newton, Eva M. Lepisto, Mia Levy, Neal I. Lindeman, James Lindsay, David Liu, Zhibin Lu, Laura E. MacConaill, Ian Maurer, David S. Maxwell, Gerrit A. Meijer, Funda Meric‐Bernstam, Christine Micheel, Clinton Miller, Gordon B. Mills, Nathanael D. Moore, Petra M. Nederlof, Larsson Omberg, John A. Orechia, Ben Ho Park, Trevor J. Pugh, Brendan Reardon, Barrett J. Rollins, Mark J. Routbort, Charles L. Sawyers, Deborah Schrag, Nikolaus Schultz, Kenna Shaw, Priyanka Shivdasani, Lillian L. Siu, David B. Solit, Gabe S. Sonke, Jean Charles Soria, Parin Sripakdeevong, Natalie Stickle, Thomas Stricker, Shawn M. Sweeney, Barry S. Taylor, Jelle J. ten Hoeve, Stacy B. Thomas, Eliezer M. Van Allen, Laura van ‘t Veer, Tony van de Velde, Harm van Tinteren, Victor E. Velculescu, Carl Virtanen, Emile E. Voest, Lucy Lu Wang, Chetna Wathoo, Stuart Watt, Celeste Yu, Thomas Yu, Emily Yu, Ahmet Zehir, Hongxin Zhang - Cancer Discovery 2017 cited by 2,004
- Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
Authors: Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg, Özcan Met, Rob Kessels, Marnix H. Geukes Foppen, Joachim Stoltenborg Granhøj, Bastiaan Nuijen, Cynthia M. Nijenhuis, Inge Jedema, Maaike van Zon, Saskia Scheij, Jos H. Beijnen, Marten Hansen, Carlijn Voermans, I.M. Noringriis, Tine J. Monberg, Rikke Boedker Holmstroem, Lidwina D.V. Wever, M. van Dijk, Lindsay G. Grijpink-Ongering, Ludy H.M. Valkenet, A. Torres Acosta, Matthias Karger, Jessica S.W. Borgers, Renske M.T. ten Ham, Valesca P. Retèl, Wim H. van Harten, Ferry Lalezari, Harm van Tinteren, Astrid A.M. van der Veldt, Geke A.P. Hospers, Marion A. M. Stevense‐den Boer, Karijn P.M. Suijkerbuijk, Maureen J.B. Aarts, Djura Piersma, Alfons J.M. van den Eertwegh, Jan‐Willem B. de Groot, Gerard Vreugdenhil, Ellen Kapiteijn, Marye J. Boers‐Sonderen, W. Edward Fiets, Franchette W.P.J. van den Berkmortel, Eva Ellebæk, Lisbet Rosenkrantz Hölmich, Alexander C. J. van Akkooi, Winan J. van Houdt, Michel W.J.M. Wouters, Johannes V. van Thienen, Christian U. Blank, A. Meerveld-Eggink, Sebastian Klobuch, Sofie Wilgenhof, Ton N. Schumacher, Marco Donia, Inge Marie Svane, John B.A.G. Haanen - New England Journal of Medicine 2022 cited by 536
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
Authors: Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings, Karolina Sikorska, Koen Van de Vijver, Michiel de Maaker, Iris Nederlof, Roelof J.C. Kluin, Sarah Warren, SuFey Ong, T. Wiersma, Nicola S. Russell, Ferry Lalezari, Philip C. Schouten, Noor A. M. Bakker, Steven L. C. Ketelaars, Dennis Peters, Charlotte A.H. Lange, Erik van Werkhoven, Harm van Tinteren, Ingrid A.M. Mandjes, Inge Kemper, Suzanne Onderwater, Myriam Chalabi, Sofie Wilgenhof, John B.A.G. Haanen, Roberto Salgado, Karin E. de Visser, Gabe S. Sonke, Lodewyk F.A. Wessels, Sabine C. Linn, Ton N. Schumacher, Christian U. Blank, Marleen Kok - Nature Medicine 2019 cited by 889
- Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
Authors: Christian U. Blank, Elisa A. Rozeman, Lorenzo F. Fanchi, Karolina Sikorska, B. van de Wiel, Pia Kvistborg, Oscar Krijgsman, Marlous van den Braber, Daisy Philips, Annegien Broeks, Johannes V. van Thienen, Henk Mallo, S. Adriaansz, Sylvia ter Meulen, Loes M. Pronk, Lindsay G. Grijpink-Ongering, Annemarie Bruining, Rachel M. Gittelman, Sarah Warren, Harm van Tinteren, Daniel S. Peeper, John B.A.G. Haanen, Alexander C. J. van Akkooi, Ton N. Schumacher - Nature Medicine 2018 cited by 855
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Authors: Willemien J. van Driel, Simone N. Koole, Karolina Sikorska, Jules H. Schagen van Leeuwen, Henk W.R. Schreuder, Ralph H.M. Hermans, Ignace H. J. T. de Hingh, Jacobus van der Velden, Henriëtte J.G. Arts, Leon F.A.G. Massuger, Arend G. J. Aalbers, Victor J. Verwaal, Jacobien M. Kieffer, Koen Van de Vijver, Harm van Tinteren, Neil K. Aaronson, Gabe S. Sonke - New England Journal of Medicine 2018 cited by 1,409
- Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
Authors: Elisa A. Rozeman, Alexander M. Menzies, Alexander C. J. van Akkooi, Chandra Mani Adhikari, Carolien Bierman, Bart A. van de Wiel, Richard A. Scolyer, Oscar Krijgsman, Karolina Sikorska, Hanna Eriksson, Annegien Broeks, Johannes V. van Thienen, Alexander Guminski, Alex Torres Acosta, Sylvia ter Meulen, Anne Miek Koenen, Linda J.W. Bosch, Kerwin F. Shannon, Loes M. Pronk, Maria Gonzalez, Sydney Ch’ng, Lindsay G. Grijpink-Ongering, Jonathan R. Stretch, Stijn W. T. P. J. Heijmink, Harm van Tinteren, John B.A.G. Haanen, Omgo E. Nieweg, W. Martin C. Klop, Charlotte L. Zuur, Robyn P.M. Saw, Winan J. van Houdt, Daniel S. Peeper, Andrew J. Spillane, Johan Hansson, Ton N. Schumacher, Georgina V. Long, Christian U. Blank - The Lancet Oncology 2019 cited by 522
- Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials
Authors: Jeremy Braybrooke, Rosie Bradley, Richard Gray, Robert K. Hills, Hongchao Pan, Richárd Pető, David Dodwell, Paul McGale, Carolyn Taylor, Tomohiko Aihara, Stewart Anderson, Joanne L. Blum, Fátima Cardoso, Xiaosong Chen, John Crown, Bent Ejlertsen, Thomas W. P. Friedl, Nadia Harbeck, Wolfgang Janni, Maj‐Britt Jensen, E. Mamounas, Kazutaka Narui, Ulrike Nitz, Larry Norton, Joyce O’Shaughnessy, Martine Piccart, Nicholas J. Robert, Zhi‐Ming Shao, Dennis Slamon, Joseph A. Sparano, Toru Watanabe, Greg Yothers, Ke‐Da Yu, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Lui, Zulian Lui, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Aman U. Buzdar, Vera J. Suman, Kelly K. Hunt, Robert Leonard, Janine Mansi, Catherine Delbaldo, Pascal Piedbois, Emmanuel Quinaux, Christian Fesl, Michael Gnant, Lidija Sölkner, Guenther G. Steger, Hans Petter Eikesdal, Per Eystein Lønning, Valerie Bée, Helena Fung, John R. Mackey, Miguel Martín, Michael F. Press, Evandro de Azambuja, Richard D. Gelber, Meredith M. Regan, Angelo Di Leo, Veerle Van Dooren, J.-M. Nogaret, John M.S. Bartlett, Bingshu E. Chen, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Kathleen I. Pritchard, Lois E. Shepherd, Donald A. Berry, Constance Cirrincione, Lawrence N. Shulman, Eric P. Winer, Rebecca Gelman, Jay R. Harris, Craig Henderson, Charles L. Shapiro, Peer Christiansen, Marianne Ewertz, Henning T. Mouridsen, Elise Van Leeuwen, Sabine C. Linn, Annelot G.J. van Rossum, Harm van Tinteren and 136 more - The Lancet 2023 cited by 189
- Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
Authors: Victor J. Verwaal, Serge van Ruth, Eelco de Bree, Gooike W. van Slooten, Harm van Tinteren, Henk Boot, F.A.N. Zoetmulder - Journal of Clinical Oncology 2003 cited by 2,027
- Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial
Authors: Ben J. Slotman, Harm van Tinteren, J. Praag, J. Knegjens, Sherif Y. El Sharouni, M. Hatton, Astrid Keijser, Corinne Faivre‐Finn, Suresh Senan - The Lancet 2014 cited by 592
- First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
Authors: Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld, Jan Willem B. de Groot, Helga Droogendijk, Helgi H. Helgason, Mathijs P. Hendriks, Joost M. Klaase, Geert Kazemier, Mike S.L. Liem, Arjen M. Rijken, Cornelis Verhoef, Johannes H.W. de Wilt, Koert P. de Jong, Michael F. Gerhards, Martinus J. van Amerongen, Marc Engelbrecht, Krijn P. van Lienden, I. Quintus Molenaar, Bart de Valk, Brigitte C.M. Haberkorn, Emile D. Kerver, Frans Erdkamp, Robbert J. van Alphen, Daniëlle Mathijssen‐van Stein, Aysun Komurcu, Marta López‐Yurda, Rutger‐Jan Swijnenburg, Cornelis J.A. Punt, Thomas van Gulik, Joost Huiskens, Harm van Tinteren, Cornelis H.C. Dejong, Dirk J. Grünhagen, Gijs A. Patijn, Theo J. M. Ruers, T. Chapelle, John J. Hermans, Wouter K. G. Leclercq, Liselot Valkenburg‐van Iersel, Cecile Grootscholten, Joyce M. van Dodewaard-de Jong, Jeroen Vincent, Danny Houtsma, Maartje Los, Marien den Boer, Marija Trajkovic-Vidakovic, Theo van Voorthuizen, Miriam Koopman, Johanneke H.M.J.V. Vestjens, Hans Torrenga, Leonie J. Mekenkamp, G.J. Veldhuis, Marco B. Polée, Serge E. Dohmen, Heidi Schut, Annelie J.E. Vulink, Henk K. van Halteren, Jamal Oulad Hadj, Pieter-Paul J.B.M. Schiphorst, Ronald Hoekstra - The Lancet Oncology 2023 cited by 168
- 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer
Authors: Victor J. Verwaal, Sjoerd C. Bruin, Henk Boot, Gooike van Slooten, Harm van Tinteren - Annals of Surgical Oncology 2008 cited by 1,025
- Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia
Authors: Linde Dekker, Friso Calkoen, Yilin Jiang, Hilly Blok, Saskia R Veldkamp, Coco de Koning, Maike Spoon, Rick Admiraal, Peter M. Hoogerbrugge, Britta Vormoor, Josef Vormoor, Henk Visscher, Marc Bierings, Marieke Van Der Vlugt, Harm van Tinteren, A. Laura Nijstad, Alwin D. R. Huitema, Kim C. M. van der Elst, Rob Pieters, Caroline A. Lindemans, Stefan Nierkens - Blood Advances 2022 cited by 85
- Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
Authors: Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken, Karolina Sikorska, Pehr Lind, Marianne Nordsmark, Elma Meershoek‐Klein Kranenbarg, Henk Boot, Anouk Kirsten Trip, H A Maurits Swellengrebel, Hanneke W.M. van Laarhoven, Hein Putter, Johanna W. van Sandick, Mark I. van Berge Henegouwen, Henk H. Hartgrink, Harm van Tinteren, Cornelis J.�H. van de Velde, Marcel Verheij, Frits van Coevorden, Steven Vanhoutvin, Maarten C.C.M. Hulshof, O. J. L. Loosveld, Albert J. ten Tije, Frans Erdkamp, Fabienne Warmerdam, Donald L. van der Peet, Henk M.W. Verheul, Djamila Boerma, Maartje Los, Annerie Slot, Danny Houtsma, Johanna EA Portielje, R.J.B. Blaisse, Ernst Jan Spillenaar Bilgen, Marco B. Polée, Maud M. Geenen, Jeffrey P. B. M. Braak, Karen J. Neelis, Marije Slingerland, Rob LH Jansen, Jeroen Buijsen, Aart Beeker, Q. A. J. Eijsbouts, Johanna MGH van Riel, Tom Rozema, Dick Johan van Spronsen, Jetske M. Meerum Terwogt, Bea C. Tanis, Adelheid ME Van der Torren-Conze, Richard van Hilligersberg, Miriam Koopman, Marien O. den Boer, Geert‐Jan Creemers, Maurice J.C. van der Sangen, Marjolein EM Rentinck, H. Pieter van den Berg, G. J. P. M. Jonkers, D.A.R.H. Grootenboers, Annelie JE Vulink, Sjoerd Hovenga, Huub CJ Van der Mijle, Arnold Baars, A. Haringhuizen, Marije IE Appels, Ron C. Rietbroek, Ellen M. Hendriksen, Marie-Cecile Legdeur, Daan ten Bokkel Huinink, O Aart Van Dobbenburgh, Jitty M. Smit, Aart van Bochove, Gerrit-Jan Veldhuis, E.W. Muller, Johannes J. Bonenkamp, Pètra M. Braam, Jaap de Boer, Henk K. van Halteren, F.A.A. Valster, Alex L.T. Imholz, Marjan A. van Dijk, Ate van der Gaast, J (Hans)-Martin MB Otten, Heleen M. Ceha, Bengt Glimelius, Cecillia Lagerbäck, Mats Perman, Anders Johnsson, David Borg, Niels Hilmer Nielsen, Andrzej Piwowar, Mattias Elmlund, Helene Hörberg, Per Edlund, Bengt Johansson, Petra Flygare, Marie Louise Jespersen - The Lancet Oncology 2018 cited by 576
- Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients
Authors: Mila Donker, Marieke E. Straver, Jelle Wesseling, Claudette E. Loo, Margaret Schot, Caroline A. Drukker, Harm van Tinteren, Gabe S. Sonke, Emiel J. Rutgers, Marie-Jeanne T. F. D. Vrancken Peeters - Annals of Surgery 2014 cited by 423
- Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675)
Authors: J. Belderbos, Dirk K.M. De Ruysscher, Katrien De Jaeger, Friederike Koppe, Maarten Lambrecht, Yolande Lievens, Edith Dieleman, Jaap Jaspers, Jan P. van Meerbeeck, Fred Ubbels, Margriet Kwint, Marianne A. Kuenen, Sabine Deprez, Michiel B. de Ruiter, Willem Boogerd, Karolina Sikorska, Harm van Tinteren, Sanne B. Schagen - Journal of Thoracic Oncology 2021 cited by 147
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)
Authors: Willem J. Koemans, Rosa T. van der Kaaij, Henk Boot, Tineke E. Buffart, A.A.F.A. Veenhof, Koen J. Hartemink, Cecile Grootscholten, Pétur Snæbjörnsson, Valesca P. Retèl, Harm van Tinteren, Steven Vanhoutvin, Vincent van der Noort, Aletta P. I. Houwink, ChangHoon Hahn, Alwin D. R. Huitema, Max J. Lahaye, Maartje Los, P. van den Barselaar, O. Imhof, Arend G. J. Aalbers, Gooitzen M. van Dam, Boudewijn van Etten, Bas P. L. Wijnhoven, Misha Luyer, Djamila Boerma, Johanna W. van Sandick - BMC Cancer 2019 cited by 114
- Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group
Authors: Lieke H. J. Simkens, Harm van Tinteren, Anne M. May, Albert J. ten Tije, Geert-Jan Creemers, O. J. L. Loosveld, Felix E. de Jongh, Frans Erdkamp, Z. Erjavec, Adelheid M E van der Torren, Jolien Tol, Hans J. Braun, Peter Nieboer, Jacobus J. M. van der Hoeven, Janny G. Haasjes, Rob L. H. Jansen, J. Wals, Annemieke Cats, Veerle A. Derleyn, A. Honkoop, L. Mol, Cornelis J.A. Punt, Miriam Koopman - The Lancet 2015 cited by 528
- Mutations in the SIX1/2 Pathway and the DROSHA/DGCR8 miRNA Microprocessor Complex Underlie High-Risk Blastemal Type Wilms Tumors
Authors: Jenny Wegert, Naveed Ishaque, Romina Vardapour, Christina Geörg, Zuguang Gu, Matthias Bieg, Barbara Ziegler, Sabrina Bausenwein, Nasenien Nourkami, Nicole Ludwig, Andreas Keller, Clemens Grimm, Susanne Kneitz, Richard D. Williams, Tas Chagtai, Kathy Pritchard‐Jones, Peter van Sluis, Richard Volckmann, Jan Köster, Rogier Versteeg, Tomás Acha, Maureen J. O’Sullivan, Peter K. Bode, Felix Niggli, Godelieve A.M. Tytgat, Harm van Tinteren, Marry M. van den Heuvel‐Eibrink, Eckart Meese, Christian Vokuhl, Ivo Leuschner, Norbert Graf, Roland Eils, Stefan M. Pfister, Marcel Kool, Manfred Gessler - Cancer Cell 2015 cited by 307
- Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol
Authors: on behalf of the International Society of Paediatric Oncology — Renal Tumour Study Group (SIOP–RTSG), Marry M. van den Heuvel‐Eibrink, Janna A. Hol, Kathy Pritchard‐Jones, Harm van Tinteren, Rhoikos Furtwängler, Arnauld Verschuur, Gordan Vujanić, Ivo Leuschner, Jesper Brok, Christian Rübe, Anne Smets, Geert O. Janssens, Jan Godziński, Gema Ramírez, Beatriz de Camargo, Heidi Segers, Paola Collini, Manfred Gessler, Christophe Bergeron, Filippo Spreafico, Norbert Graf - Nature Reviews Urology 2017 cited by 377
- Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)
Authors: Elisa A. Rozeman, Warner Prevoo, Mark A. Meier, Karolina Sikorska, Trieu My Van, Bart A. van de Wiel, Jacqueline E. van der Wal, Henk Mallo, Lindsay G. Grijpink-Ongering, Annegien Broeks, Ferry Lalezari, Jason Reeves, Sarah Warren, Johannes V. van Thienen, Harm van Tinteren, John B.A.G. Haanen, Ellen Kapiteijn, Christian U. Blank - Melanoma Research 2020 cited by 52
- Cognitive and Behavioral Development of 9-Year-Old Children After Maternal Cancer During Pregnancy: A Prospective Multicenter Cohort Study
Authors: Indra A. Van Assche, Evangeline A. Huis in ’t Veld, Kristel Van Calsteren, Mathilde van Gerwen, Jeroen Blommaert, Elyce Cardonick, Michael J. Halaška, Robert Fruscio, Monica Fumagalli, Jurgen Lemiere, Elisabeth M. van Dijk‐Lokkart, Camilla Fontana, Harm van Tinteren, Jessie De Ridder, Martine van Grotel, Marry M. van den Heuvel‐Eibrink, Lieven Lagae, Frédéric Amant - Journal of Clinical Oncology 2023 cited by 31
- Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study
Authors: Marie José Kersten, Julia Driessen, Josée M. Zijlstra, Wouter J. Plattel, Franck Morschhauser, Pieternella J. Lugtenburg, Pauline Brice, Martin Hutchings, Thomas Gastinne, Roberto Liu, Coreline N. Burggraaff, Marcel Nijland, Sanne H. Tonino, Anne I.J. Arens, Roelf Valkema, Harm van Tinteren, Marta López‐Yurda, Arjan Diepstra, Daphne de Jong, Anton Hagenbeek - Haematologica 2020 cited by 102
- Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
Authors: Jan B. Vermorken, A.M.E. Claessen, Harm van Tinteren, Helen Gall, Renate Ezinga, Sybren L. Meijer, Rik J. Scheper, Chris J.L.M. Meijer, Elisabeth Bloemena, Janet H. Ransom, Michael G. Hanna, Herbert M. Pinedo - The Lancet 1999 cited by 503
- Clinical Prediction Model To Characterize Pulmonary Nodules
Authors: Gerarda J.M. Herder, Harm van Tinteren, Richard P. Golding, Piet J. Kostense, Emile F.I. Comans, Egbert F. Smit, Otto S. Hoekstra - CHEST Journal 2005 cited by 392
